ABC7

FDA advisers sign off on Johnson & Johnson vaccine: Here's what happens next

An independent advisory panel of infectious disease experts, doctors and scientists voted unanimously to recommend the COVID-19 vaccine from Johnson & Johnson for emergency use authorization from the ...
KSHB 41 Kansas City

FDA seizes thousands of 7-OH products from KC-based company following danger warning of products

KSHB 41 News reporter Isabella Ledonne's Strong High Weak Laws series continues to amplify the community's concerns about ...
Seeking Alpha

Johnson & Johnson receives FDA approval for IMAAVY™ (nipocalimab-aahu), a new FcRn blocker offering long-lasting disease control in the broadest population of people living ...

First and only FcRn blocker approved in anti-AChR and anti-MuSK antibody positive adults and pediatric gMG patients aged 12 and older IMAAVY delivered rapid and substantial reduction in immunoglobulin ...
Nasdaq

Could This Game-Changing FDA Approval Mean Profit for Johnson & Johnson Shareholders?

Earlier this month, the U.S. Food and Drug Administration approved Johnson & Johnson's (NYSE: JNJ) Invega Hafyera, the first and only twice-yearly injectable drug to treat schizophrenia. This FDA ...